Avalon GloboCare (ALBT) had the highest return between March 1, 2018 and April 30, 2018 by a US stock, returning 3,249,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | 3/1/2018 - 4/30/2018 | 3,249,900% |
Neuroone Medical Technologies (NMTC) | 3/1/2018 - 4/30/2018 | 638,233.33% |
GT Biopharma (GTBP) | 3/1/2018 - 4/30/2018 | 41,173.2% |
Nocera (NCRA) | 3/1/2018 - 4/30/2018 | 982.68% |
Creative Medical Technology (CELZ) | 3/1/2018 - 4/30/2018 | 630.46% |
Reliance Global (RELI) | 3/1/2018 - 4/30/2018 | 414.91% |
Thryv (THRY) | 3/1/2018 - 4/30/2018 | 336.83% |
INVO Fertility (IVF) | 3/1/2018 - 4/30/2018 | 276.47% |
TON Strategy (TONX) | 3/1/2018 - 4/30/2018 | 242.22% |
Genprex (GNPX) | 3/1/2018 - 4/30/2018 | 230.28% |
Ryvyl (RVYL) | 3/1/2018 - 4/30/2018 | 209.98% |
Turtle Beach (TBCH) | 3/1/2018 - 4/30/2018 | 204.2% |
Aemetis (AMTX) | 3/1/2018 - 4/30/2018 | 201.79% |
Arcadia Biosciences (RKDA) | 3/1/2018 - 4/30/2018 | 172.15% |
Rafael (RFL) | 3/1/2018 - 4/30/2018 | 168.85% |
OLB (OLB) | 3/1/2018 - 4/30/2018 | 166.67% |
BlueLinx (BXC) | 3/1/2018 - 4/30/2018 | 159.48% |
American Resources Corp Class A (AREC) | 3/1/2018 - 4/30/2018 | 145.15% |
Tandem Diabetes Care (TNDM) | 3/1/2018 - 4/30/2018 | 140.69% |
Eyepoint Pharmaceuticals (EYPT) | 3/1/2018 - 4/30/2018 | 134.29% |
Golden Matrix (GMGI) | 3/1/2018 - 4/30/2018 | 125% |
Bone Biologics (BBLG) | 3/1/2018 - 4/30/2018 | 103.05% |
ImmunoPrecise Antibodies (HYFT) | 3/1/2018 - 4/30/2018 | 96.84% |
Relmada Therapeutics (RLMD) | 3/1/2018 - 4/30/2018 | 94.67% |
Odyssey Marine Exploration (OMEX) | 3/1/2018 - 4/30/2018 | 94.33% |
